Have a personal or library account? Click to login
Development of human cell biosensor system for genotoxicity detection based on DNA damage-induced gene expression Cover

Development of human cell biosensor system for genotoxicity detection based on DNA damage-induced gene expression

Open Access
|Mar 2010

References

  1. Elespuru RK, Agarwal R, Atrakchi AH, Bigger CAH, Heflich RH, Jagannath DR, et al. Current and Future Application of Genetic Toxicity Assays: The Role and Value of In Vitro Mammalian Assays. Toxicol Sci 2009; 109: 172-9.10.1093/toxsci/kfp067
  2. Sutton MD, Smith BT, Godoy VG, Walker GC. The SOS response: Recent insights into umuDC-dependent mutagenesis and DNA damage tolerance. Ann Rev Genet 2000; 34: 479-97.10.1146/annurev.genet.34.1.479
  3. Putnam CD, Jaehnig EJ, Kolodner RD. Perspectives on the DNA damage and replication checkpoint responses in Saccharomyces cerevisiae. DNA Repair 2009; 8: 974-82.10.1016/j.dnarep.2009.04.021
  4. Holbrook NJ, Fornace AJ. Response to adversity - molecular control of gene activation following genotoxic stress. New Biologist 1991; 3: 825-33.
  5. Quillardet P, Huisman O, Dari R, Hofnung M. SOS chromotest, a direct assay of induction of an sos function in escherichia-coli k-12 to measure genotoxicity. P Natl Acad Sci USA 1982; 79: 5971-5.10.1073/pnas.79.19.5971
  6. Oda Y, Nakamura S, Oki I, Kató T, Shinagawa H. Evaluation of the new system (umu-test) for the detection of environmental mutagens and carcinogens. Mutat Res 1985; 147: 219-29.10.1016/0165-1161(85)90062-7
  7. Walmsley RM, Billinton N, Walsh L, Barker MG, Knight AW, Cahill PA. A yeast RAD54-GFP genotoxicity assay, is effective in identifying direct acting mutagens in addition to clastogens not detected by bacterial tests. Toxicol Sci 2003; 72: 1106.
  8. Liu X, Kramer JA, Swaffield JC, Hu Y, Chai G, Wilson AGE. Development of a highthroughput yeast-based assay for detection of metabolically activated genotoxins. Mutat Res-Gen Tox En 2008; 653: 63-9.10.1016/j.mrgentox.2008.03.00618485802
  9. Zhou B-BS, Elledge SJ. The DNA damage response: putting checkpoints in perspective. Nature 2000; 408: 433-9.10.1038/3504400511100718
  10. Sionov RV, Haupt Y. The cellular response to p53: the decision between life and death. Oncogene 1999; 18: 6145-57.10.1038/sj.onc.120313010557106
  11. Waldman T, Kinzler KW, Vogelstein B. P21 is necessary for the P53-mediated G1 arrest in human cancer cells. Cancer Res 1995; 55: 5187-90.
  12. Vogelstein B, Lane D, Levine AJ. Surfing the p53 network. Nature 2000; 408: 307-10.10.1038/3504267511099028
  13. Moldovan G-L, Pfander B, Jentsch S. PCNA, the maestro of the replication fork. Cell 2007; 129: 665-79.10.1016/j.cell.2007.05.00317512402
  14. Park SY, Lee SM, Ye SK, Yoon SH, Chung MH, Choi J. Benzo[a]pyrene-induced DNA damage and p53 modulation in human hepatoma HepG2 cells for the identification of potential biomarkers for PAH monitoring and risk assessment. Toxicol Lett 2006; 167: 27-33.10.1016/j.toxlet.2006.08.01117029827
  15. Zegura B, Zajc I, Lah TT, Filipic M. Patterns of microcystin-LR induced alteration of the expression of genes involved in response to DNA damage and apoptosis. Toxicon 2008; 51: 615-23.10.1016/j.toxicon.2007.11.00918191168
  16. Hreljac I, Zajc I, Lah T, Filipic M. Effects of model organophosphorous pesticides on DNA damage and proliferation of HepG2 cells. Environ Mol Mutagen 2008; 49: 360-7.10.1002/em.2039218418871
  17. Ellinger-Ziegelbauer H, Stuart B, Wahle B, Bomann W, Ahr HJ. Comparison of the expression profiles induced by genotoxic and nongenotoxic carcinogens in rat liver. Mutat Res-Gen Tox En 2005; 575: 61-84.10.1016/j.mrfmmm.2005.02.00415890375
  18. Knasmuller S, Mersch-Sundermann V, Kevekordes S, Darroudi F, Huber WW, Hoelzl C, et al.. Use of human-derived liver cell lines for the detection of environmental and dietary genotoxicants; current state of knowledge. Toxicology 2004; 198: 315-28.10.1016/j.tox.2004.02.00815138058
  19. Bressac B, Galvin KM, Liang TJ, Isselbacher KJ, Wands JR, Ozturk M. Abnormal structure and expression of p53 gene in human hepatocellular-carcinoma. P Natl Acad Sci USA 1990; 87: 1973-7.10.1073/pnas.87.5.1973536072155427
  20. Mesojednik S, Kamensek U, Cemazar M. Evaluation of shRNA-mediated gene silencing by electroporation in LPB fibrosarcoma cells. Radiol Oncol 2008; 42: 82-92.10.2478/v10019-008-0007-3
  21. Todd MD, Lee MJ, Williams JL, Nalezny JM, Gee P, Benjamin MB, et al. The cat-tox (l) assay - a sensitive and specific measure of stress-induced transcription in transformed human liver-cells. Fund Appl Toxicol 1995; 28: 118-28.10.1006/faat.1995.11538566476
  22. Tanaka H, Arakawa H, Yamaguchi T, Shiraishi K, Fukuda S, Matsui K, et al. A ribonucleotide reductase gene involved in a p53-dependent cell-cycle checkpoint for DNA damage. Nature 2000; 404: 42-9.10.1038/3500350610716435
  23. Guittet O, Hakansson P, Voevodskaya N, Fridd S, Graslund A, Arakawa H, et al. Mammalian p53R2 protein forms an active ribonucleotide reductase in vitro with the R1 protein, which is expressed both in resting cells in response to DNA damage and in proliferating cells. J Biol Chem 2001; 276: 40647-51.10.1074/jbc.M10608820011517226
  24. Ohno K, Tanaka-Azuma Y, Yoneda Y, Yamada T. Genotoxicity test system based on p53R2 gene expression in human cells: Examination with 80 chemicals. Mutat Res-Gen Tox En 2005; 588: 47-57.10.1016/j.mrgentox.2005.09.002
  25. Ohno K, Ishihata K, Tanaka-Azuma Y, Yamada T. A genotoxicity test system based on p53R2 gene expression in human cells: Assessment of its reactivity to various classes of genotoxic chemicals. Mutat Res-Gen Tox En 2008; 656: 27-35.10.1016/j.mrgentox.2008.07.002
  26. Siafakas RA, Richardson DR. Growth arrest and DNA damage-45 alpha (GADD45α). Int J BiochemCell B 2009; 41: 986-9.
  27. Hastwell PW, Chai LL, Roberts KJ, Webster TW, Harvey JS, Rees RW, et al. High-specificity and high-sensitivity genotoxicity assessment in a human cell line: Validation of the GreenScreen HC GADD45a-GFP genotoxicity assay. Mutat Res-Gen Tox En 2006; 607: 160-75.10.1016/j.mrgentox.2006.04.011
  28. Birrell L, Cahill P, Hughes C, Tate M, Walmsley RM. GADD45a-GFP GreenScreen HC assay results for the ECVAM recommended lists of genotoxic and non-genotoxic chemicals for assessment of new genotoxicity tests. Mutat Res-Gen Tox En 2010; 695: 87-95.10.1016/j.mrgentox.2009.12.008
  29. Zhang R, Niu YJ, Do HR, Cao XW, Shi D, Hao QL, et al. A stable and sensitive testing system for potential carcinogens based on DNA damage-induced gene expression in human HepG2 cell. Toxicol In Vitro 2009; 23: 158-65.10.1016/j.tiv.2008.10.006
  30. Yang TT, Cheng LZ, Kain SR. Optimized codon usage and chromophore mutations provide enhanced sensitivity with the green fluorescent protein. Nucleic Acids Res 1996; 24: 4592-3.10.1093/nar/24.22.4592
  31. Cormack BP, Valdivia RH, Falkow S. FACS-optimized mutants of the green fluorescent protein (GFP). Gene 1996; 173: 33-8.10.1016/0378-1119(95)00685-0
  32. Lawley PD. Mutagens as carcinogens - development of current concepts. Mutat Res 1989; 213: 3-25.10.1016/0027-5107(89)90028-6
  33. Beranek DT. Distribution of methyl and ethyl adducts following alkylation with monofunctional alkylating-agents. Mutat Res 1990; 231: 11-30.10.1016/0027-5107(90)90173-2
  34. Jaiswal AS, Narayan S. S(N)2 DNA-alkylating agent-induced phosphorylation of p53 and activation of p21 gene expression. Mutat Res-Fund Mol M 2002; 500: 17-30.10.1016/S0027-5107(01)00296-2
  35. Perlow RA, Kolbanovskii A, Hingerty BE, Geacintov NE, Broyde S, Scicchitano DA. DNA adducts from a tumorigenic metabolite of benzo[a]pyrene block human RNA polymerase II elongation in a sequence- and stereochemistry-dependent manner. J Mol Biol 2002; 321: 29-47.10.1016/S0022-2836(02)00593-4
  36. Wang A, Gu J, Judson-Kremer K, Powell KL, Mistry H, Simhambhatla P, et al. Response of human mammary epithelial cells to DNA damage induced by BPDE: involvement of novel regulatory pathways. Carcinogenesis 2003; 24: 225-34.10.1093/carcin/24.2.22512584171
  37. Sadikovic B, Rodenhiser DI. Benzopyrene exposure disrupts DNA methylation and growth dynamics in breast cancer cells. Toxicol Appl Pharm 2006; 216: 458-68.10.1016/j.taap.2006.06.01216926039
  38. Jagger C, Tate M, Cahill PA, Hughes C, Knight AW, Billinton N, et al. Assessment of the genotoxicity of S9-generated metabolites using the GreenScreen HC GADD45a-GFP assay. Mutagenesis 2009; 24: 35-50.10.1093/mutage/gen05018787182
  39. Corda Y, Job C, Anin MF, Leng M, Job D. Spectrum of DNA platinum adduct recognition by prokaryotic and eukaryotic DNA-dependent RNA-polymerases. Biochemistry 1993; 32: 8582-8.10.1021/bi00084a0277689335
  40. Pabla N, Huang S, Mi QS, Daniel R, Dong Z. ATR-Chk2 signaling in p53 activation and DNA damage response during cisplatin-induced apoptosis. J Biol Chem 2008; 283: 6572-83.10.1074/jbc.M70756820018162465
  41. Marini F, Nardo T, Giannattasio M, Minuzzo M, Stefanini M, Plevani P, et al.. DNA nucleotide excision repair-dependent signaling to checkpoint activation. P Natl Acad Sci USA 2006; 103: 17325-30.10.1073/pnas.0605446103185992917088560
  42. Owellen RJ, Hartke CA, Dickerson RM, Hains FO. Inhibition of tubulin-microtubule polymerization by drugs of vinca alkaloid class. Cancer Res 1976; 36: 1499-502.
  43. Tishler RB, Lamppu DM, Park S, Price BD. Microtubule-active drugs taxol, vinblastine, and nocodazole increase the levels of transcriptionally active P53. Cancer Res 1995; 55: 6021-5.
DOI: https://doi.org/10.2478/v10019-010-0010-3 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Language: English
Page range: 42 - 51
Published on: Mar 18, 2010
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2010 Valerija Zager, Maja Cemazar, Irena Hreljac, Tamara Lah, Gregor Sersa, Metka Filipic, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons License.

Volume 44 (2010): Issue 1 (March 2010)